Cover Image
Market Research Report

Global Infectious Disease Testing Market By Product & Service, By Technology, By Disease, By End User, By Region, Forecast & Opportunities, 2025

Published by TechSci Research Product code 938724
Published Content info 112 Pages
Delivery time: Inquiry
Price

We offer 8 hour analyst time for an additional research. Please contact us for the details.

Back to Top
Global Infectious Disease Testing Market By Product & Service, By Technology, By Disease, By End User, By Region, Forecast & Opportunities, 2025
Published: May 1, 2020 Content info: 112 Pages
Description

Global infectious disease testing market is expected to grow at a significant CAGR during the forecast period. The global infectious disease testing market is driven by rising populace having infectious diseases across the globe. Moreover, investments in healthcare infrastructure by governments across the globe is expected to fuel the growth of market during the forecast period. Also, increase in research and developmental activities in the healthcare sector is further expected to bolster the growth of market over the next few years.

The global infectious disease testing market is segmented based on product and service, technology, disease, end user, company, and region. Based on product and service, the market can be categorized into assays, kits, & reagents; instruments; services & software. Out of which, the assays, kits, & reagents segment dominated the market in terms of largest market share during the forecast period and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to ease of accessibility coupled with rising number of IDD tests that are being conducted. In addition to this, the volume of IDD tests is growing primarily because of increasing geriatric population along with rising incidence of infectious diseases. Moreover, ongoing development of newer, faster, and more reliable products is further anticipated to boost the growth of segment over the coming years. Along with that, the reagents are available in variety, which is further aiding the market growth.

Major players operating in the global infectious disease testing market include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, Johnson and Johnson, F. Hoffmann-La Roche Ltd, Cepheid, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global infectious disease testing market from 2015 to 2018.
  • To estimate and forecast the market size of global infectious disease testing market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global infectious disease testing market based on product and service, technology, disease, end user, company and regional distribution.
  • To identify dominant region or segment in the global infectious disease testing market.
  • To identify drivers and challenges for global infectious disease testing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global infectious disease testing market.
  • To conduct pricing analysis for global infectious disease testing market.
  • To identify and analyze the profile of leading players operating in global infectious disease testing market.
  • To identify key sustainable strategies adopted by market players in global infectious disease testing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global infectious disease testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Infectious disease testing hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to infectious disease testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global infectious disease testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Infectious Disease Testing Market, By Product and Service:

Assays, Kits, & Reagents

Instruments

Services & Software

  • Global Infectious Disease Testing Market, By Technology:

Immunodiagnostics

Clinical Microbiology

Polymerase Chain Reaction

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-Generation Sequencing

DNA Microarray

Other Technologies

  • Global Infectious Disease Testing Market, By Disease:

Hepatitis

HIV

HAIS

HPV

TB

Influenza

Glandular fever

Coronavirus

Others

  • Global Infectious Disease Testing Market, By End User:

Hospital/Clinical Laboratories

Reference Laboratories

Physician Offices

Academic/Research Institutes

Other

  • Global Infectious Disease Testing Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Netherland
  • Russia
  • Turkey

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Malaysia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global infectious disease testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Table of Contents
Product Code: 4695

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Infectious Disease Testing Market

4. Executive Summary

5. Voice of Customer

6. Global Infectious Disease Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software)
    • 6.2.2. By Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Other Technologies)
    • 6.2.3. By Disease (Hepatitis, HIV, HAIS, HPV, TB, Influenza, Glandular fever, Coronavirus, Others)
    • 6.2.4. By End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Infectious Disease Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By Technology
    • 7.2.3. By Disease
    • 7.2.4. By End User
    • 7.2.5. By Country
    • 7.2.6. Competition Outlook
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Infectious Disease Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product and Service
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Disease
        • 7.3.1.2.4. By End User
    • 7.3.2. India Infectious Disease Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product and Service
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Disease
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia Infectious Disease Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product and Service
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Disease
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan Infectious Disease Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product and Service
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Disease
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea Infectious Disease Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product and Service
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Disease
        • 7.3.5.2.4. By End User
    • 7.3.6. Indonesia Infectious Disease Testing Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Product and Service
        • 7.3.6.2.2. By Technology
        • 7.3.6.2.3. By Disease
        • 7.3.6.2.4. By End User
    • 7.3.7. Singapore Infectious Disease Testing Market Outlook
      • 7.3.7.1. Market Size & Forecast
        • 7.3.7.1.1. By Value
      • 7.3.7.2. Market Share & Forecast
        • 7.3.7.2.1. By Product and Service
        • 7.3.7.2.2. By Technology
        • 7.3.7.2.3. By Disease
        • 7.3.7.2.4. By End User
    • 7.3.8. Malaysia Infectious Disease Testing Market Outlook
      • 7.3.8.1. Market Size & Forecast
        • 7.3.8.1.1. By Value
      • 7.3.8.2. Market Share & Forecast
        • 7.3.8.2.1. By Product and Service
        • 7.3.8.2.2. By Technology
        • 7.3.8.2.3. By Disease
        • 7.3.8.2.4. By End User

8. Europe Infectious Disease Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By Technology
    • 8.2.3. By Disease
    • 8.2.4. By End User
    • 8.2.5. By Country
    • 8.2.6. Competition Outlook
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Infectious Disease Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product and Service
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Disease
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Infectious Disease Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product and Service
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Disease
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Infectious Disease Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product and Service
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Disease
        • 8.3.3.2.4. By End Use
    • 8.3.4. Italy Infectious Disease Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product and Service
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Disease
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Infectious Disease Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product and Service
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Disease
        • 8.3.5.2.4. By End User
    • 8.3.6. Netherland Infectious Disease Testing Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Product and Service
        • 8.3.6.2.2. By Technology
        • 8.3.6.2.3. By Disease
        • 8.3.6.2.4. By End User
    • 8.3.7. Russia Infectious Disease Testing Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Product and Service
        • 8.3.7.2.2. By Technology
        • 8.3.7.2.3. By Disease
        • 8.3.7.2.4. By End User
    • 8.3.8. Turkey Infectious Disease Testing Market Outlook
      • 8.3.8.1. Market Size & Forecast
        • 8.3.8.1.1. By Value
      • 8.3.8.2. Market Share & Forecast
        • 8.3.8.2.1. By Product and Service
        • 8.3.8.2.2. By Technology
        • 8.3.8.2.3. By Disease
        • 8.3.8.2.4. By End User

9. North America Infectious Disease Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By Technology
    • 9.2.3. By Disease
    • 9.2.4. By End User
    • 9.2.5. By Country
    • 9.2.6. Competition Outlook
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Infectious Disease Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product and Service
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Disease
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico Infectious Disease Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product and Service
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Disease
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada Infectious Disease Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product and Service
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Disease
        • 9.3.3.2.4. By End User

10. South America Infectious Disease Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service
    • 10.2.2. By Technology
    • 10.2.3. By Disease
    • 10.2.4. By End User
    • 10.2.5. By Country
    • 10.2.6. Competition Outlook
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Infectious Disease Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product and Service
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Disease
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Infectious Disease Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product and Service
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Disease
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Infectious Disease Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product and Service
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Disease
        • 10.3.3.2.4. By End Use

11. Middle East and Africa Infectious Disease Testing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product and Service
    • 11.2.2. By Technology
    • 11.2.3. By Disease
    • 11.2.4. By End User
    • 11.2.5. By Country
    • 11.2.6. Competition Outlook
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Infectious Disease Testing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product and Service
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Disease
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Infectious Disease Testing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product and Service
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Disease
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Infectious Disease Testing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product and Service
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Disease
        • 11.3.3.2.4. By End User
    • 11.3.4. Egypt Infectious Disease Testing Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product and Service
        • 11.3.4.2.2. By Technology
        • 11.3.4.2.3. By Disease
        • 11.3.4.2.4. By End User
    • 11.3.5. Nigeria Infectious Disease Testing Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product and Service
        • 11.3.5.2.2. By Technology
        • 11.3.5.2.3. By Disease
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Abbott Laboratories
  • 15.2. Becton, Dickinson and Company
  • 15.3. Biomerieux SA
  • 15.4. Bio-Rad Laboratories
  • 15.5. Danaher Corporation
  • 15.6. Diasorin
  • 15.7. Luminex
  • 15.8. Meridian Bioscience
  • 15.9. Quidel
  • 15.10. Roche Diagnostics
  • 15.11. Siemens AG
  • 15.12. Thermo Fisher Scientific
  • 15.13. Johnson and Johnson
  • 15.14. F. Hoffmann-La Roche Ltd
  • 15.15. Cepheid

16. Strategic Recommendations

17. About Us & Disclaimer

Back to Top